(Q58047301)

2

Sholom Wacholder

0 references

David J. Hunter

8

David J. Hunter

0 references

Frank B. Hu

4

Frank B. Hu

0 references

Marilyn C Cornelis

3

Marilyn C. Cornelis

0 references

Richard B Hayes

5

Richard B. Hayes

0 references

Peter Kraft

1

Peter Kraft

0 references

Robert N. Hoover

7

Robert Hoover

0 references

author name string

Gilles Thomas

https://scigraph.springernature.com/pub.10.1038/nrg2516

6

0 references

publication date

April 2009

0 references

published in

Nature Reviews Genetics

0 references

volume

10

0 references

page(s)

264-269

0 references

issue

4

0 references

exact match

0 references

cites work

When can a risk factor be used as a worthwhile screening test?

1 reference

Screening and follow-up of the patient at high risk for breast cancer

21 January 2018

1 reference

A HapMap harvest of insights into the genetics of common disease

21 January 2018

1 reference

Use and misuse of population attributable fractions.

31 March 2020

1 reference

Multiple loci identified in a genome-wide association study of prostate cancer

31 March 2020

1 reference

Cumulative association of five genetic variants with prostate cancer

31 March 2020

1 reference

Combining information from common type 2 diabetes risk polymorphisms improves disease prediction

31 March 2020

1 reference

Polymorphisms associated with cholesterol and risk of cardiovascular events

31 March 2020

1 reference

Guiding aerosol deposition in the lung

31 March 2020

1 reference

Five Genetic Variants Associated with Prostate Cancer

31 March 2020

1 reference

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

31 March 2020

1 reference

Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration

31 March 2020

1 reference

Genome-based prediction of common diseases: advances and prospects

31 March 2020

1 reference

Why Most Discovered True Associations Are Inflated

31 March 2020

1 reference

Curses--winner's and otherwise--in genetic epidemiology

31 March 2020

1 reference

Genetic epidemiology and public health: hope, hype, and future prospects

31 March 2020

1 reference

The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

31 March 2020

1 reference

Letting the genome out of the bottle--will we get our wish?

31 March 2020

1 reference

What is the clinical utility of genetic testing?

31 March 2020

1 reference

The limitations of risk factors as prognostic tools

31 March 2020

1 reference

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

31 March 2020

1 reference

The influence of finasteride on the development of prostate cancer

31 March 2020

1 reference

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

31 March 2020

1 reference

Screening for prostate cancer in U.S. men ACPM position statement on preventive practice

31 March 2020

1 reference

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

31 March 2020

1 reference

Human papillomavirus and cervical cancer

31 March 2020

1 reference

On the use of population-based registries in the clinical validation of genetic tests for disease susceptibility

31 March 2020

1 reference

On criteria for evaluating models of absolute risk

31 March 2020

1 reference

Genome-wide association study identifies novel breast cancer susceptibility loci

31 March 2020

1 reference

Multiple newly identified loci associated with prostate cancer susceptibility

31 March 2020

1 reference

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

31 March 2020

1 reference

Polygenes, risk prediction, and targeted prevention of breast cancer

31 March 2020

1 reference

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

31 March 2020

1 reference

31 March 2020

The Genomics Gold Rush

1 reference

Estimating the population attributable risk for multiple risk factors using case-control data

31 March 2020

1 reference

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

31 March 2020

1 reference

Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes

31 March 2020

1 reference

Genome-wide association studies provide new insights into type 2 diabetes aetiology

31 March 2020

1 reference

Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes

31 March 2020

1 reference

Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes

31 March 2020

1 reference

Predictive testing for complex diseases using multiple genes: fact or fiction?

31 March 2020

1 reference

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

31 March 2020

1 reference

Use and misuse of the receiver operating characteristic curve in risk prediction

31 March 2020

1 reference

Prostate-specific antigen screening: friend or foe?

31 March 2020

1 reference

12 December 2020

5-alpha-reductase inhibitors for prostate cancer prevention

1 reference

12 December 2020

Attributable risk percent in case-control studies

1 reference

12 December 2020

Five genetic variants associated with prostate cancer

1 reference

12 December 2020